Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
618.2
INR
|
-2.06%
|
|
-0.41%
|
+67.84%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,972
|
1,410
|
1,778
|
3,538
|
3,209
|
Enterprise Value (EV)
1 |
2,300
|
1,829
|
1,852
|
3,294
|
2,538
|
P/E ratio
|
11.9
x
|
5.57
x
|
-21.8
x
|
12.4
x
|
5.01
x
|
Yield
|
0.88%
|
1.24%
|
-
|
0.5%
|
0.55%
|
Capitalization / Revenue
|
1.02
x
|
0.69
x
|
0.98
x
|
1.3
x
|
0.97
x
|
EV / Revenue
|
1.19
x
|
0.89
x
|
1.02
x
|
1.21
x
|
0.77
x
|
EV / EBITDA
|
3.83
x
|
3.33
x
|
7.95
x
|
5.74
x
|
2.31
x
|
EV / FCF
|
-11
x
|
-6.62
x
|
10.2
x
|
12.4
x
|
9.5
x
|
FCF Yield
|
-9.09%
|
-15.1%
|
9.77%
|
8.08%
|
10.5%
|
Price to Book
|
0.79
x
|
0.51
x
|
0.67
x
|
1.19
x
|
0.89
x
|
Nbr of stocks (in thousands)
|
13,891
|
13,930
|
14,061
|
14,134
|
14,182
|
Reference price
2 |
142.0
|
101.2
|
126.4
|
250.4
|
226.2
|
Announcement Date
|
5/30/19
|
6/30/20
|
6/30/21
|
8/23/22
|
8/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,796
|
1,932
|
2,045
|
1,808
|
2,716
|
3,314
|
EBITDA
1 |
517.8
|
600.8
|
549.8
|
233
|
574
|
1,100
|
EBIT
1 |
401.8
|
458.9
|
302.3
|
35.14
|
355.9
|
877.1
|
Operating Margin
|
22.37%
|
23.75%
|
14.78%
|
1.94%
|
13.1%
|
26.47%
|
Earnings before Tax (EBT)
1 |
397.8
|
284.8
|
267.1
|
20.26
|
391
|
894.4
|
Net income
1 |
254.7
|
167.6
|
254.5
|
-81.32
|
287.5
|
645.8
|
Net margin
|
14.18%
|
8.67%
|
12.44%
|
-4.5%
|
10.58%
|
19.49%
|
EPS
2 |
18.16
|
11.96
|
18.16
|
-5.810
|
20.20
|
45.14
|
Free Cash Flow
1 |
-27.47
|
-209.1
|
-276.3
|
180.8
|
266.3
|
267.1
|
FCF margin
|
-1.53%
|
-10.82%
|
-13.51%
|
10%
|
9.81%
|
8.06%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
77.63%
|
46.39%
|
24.27%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
92.64%
|
41.35%
|
Dividend per Share
2 |
1.250
|
1.250
|
1.250
|
-
|
1.250
|
1.250
|
Announcement Date
|
7/11/18
|
5/30/19
|
6/30/20
|
6/30/21
|
8/23/22
|
8/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
159
|
327
|
419
|
73.9
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
244
|
671
|
Leverage (Debt/EBITDA)
|
0.3072
x
|
0.5451
x
|
0.7627
x
|
0.3174
x
|
-
|
-
|
Free Cash Flow
1 |
-27.5
|
-209
|
-276
|
181
|
266
|
267
|
ROE (net income / shareholders' equity)
|
11.3%
|
6.88%
|
9.66%
|
-3%
|
10.2%
|
19.6%
|
ROA (Net income/ Total Assets)
|
8.76%
|
9.26%
|
5.65%
|
0.64%
|
6.47%
|
14.3%
|
Assets
1 |
2,907
|
1,809
|
4,507
|
-12,650
|
4,440
|
4,502
|
Book Value Per Share
2 |
171.0
|
181.0
|
198.0
|
190.0
|
211.0
|
255.0
|
Cash Flow per Share
2 |
4.700
|
0.7500
|
0.0300
|
0.0100
|
1.560
|
0.6900
|
Capex
1 |
262
|
530
|
623
|
73.4
|
202
|
576
|
Capex / Sales
|
14.56%
|
27.45%
|
30.44%
|
4.06%
|
7.44%
|
17.39%
|
Announcement Date
|
7/11/18
|
5/30/19
|
6/30/20
|
6/30/21
|
8/23/22
|
8/5/23
|
|
1st Jan change
|
Capi.
|
---|
| +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +16.93% | 14.96B | | +7.73% | 15.03B |
Other Commodity Chemicals
|